ABOS
Price
$1.24
Change
-$0.04 (-3.12%)
Updated
Sep 23, 04:59 PM (EDT)
Capitalization
74.51M
54 days until earnings call
GLSI
Price
$10.99
Change
-$0.81 (-6.86%)
Updated
Sep 23, 04:59 PM (EDT)
Capitalization
160.84M
48 days until earnings call
Interact to see
Advertisement

ABOS vs GLSI

Header iconABOS vs GLSI Comparison
Open Charts ABOS vs GLSIBanner chart's image
Acumen Pharmaceuticals
Price$1.24
Change-$0.04 (-3.12%)
Volume$219
Capitalization74.51M
Greenwich LifeSciences
Price$10.99
Change-$0.81 (-6.86%)
Volume$8.11K
Capitalization160.84M
ABOS vs GLSI Comparison Chart in %
Loading...
ABOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GLSI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABOS vs. GLSI commentary
Sep 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABOS is a Hold and GLSI is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 24, 2025
Stock price -- (ABOS: $1.28 vs. GLSI: $11.80)
Brand notoriety: ABOS and GLSI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABOS: 88% vs. GLSI: 96%
Market capitalization -- ABOS: $74.51M vs. GLSI: $160.84M
ABOS [@Biotechnology] is valued at $74.51M. GLSI’s [@Biotechnology] market capitalization is $160.84M. The market cap for tickers in the [@Biotechnology] industry ranges from $97.36B to $0. The average market capitalization across the [@Biotechnology] industry is $1.92B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABOS’s FA Score shows that 0 FA rating(s) are green whileGLSI’s FA Score has 0 green FA rating(s).

  • ABOS’s FA Score: 0 green, 5 red.
  • GLSI’s FA Score: 0 green, 5 red.
According to our system of comparison, both ABOS and GLSI are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABOS’s TA Score shows that 4 TA indicator(s) are bullish while GLSI’s TA Score has 8 bullish TA indicator(s).

  • ABOS’s TA Score: 4 bullish, 6 bearish.
  • GLSI’s TA Score: 8 bullish, 2 bearish.
According to our system of comparison, GLSI is a better buy in the short-term than ABOS.

Price Growth

ABOS (@Biotechnology) experienced а +1.59% price change this week, while GLSI (@Biotechnology) price change was +1.03% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.94%. For the same industry, the average monthly price growth was +8.31%, and the average quarterly price growth was +48.45%.

Reported Earning Dates

ABOS is expected to report earnings on Nov 17, 2025.

GLSI is expected to report earnings on Nov 10, 2025.

Industries' Descriptions

@Biotechnology (+2.94% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GLSI($161M) has a higher market cap than ABOS($74.5M). GLSI YTD gains are higher at: 5.076 vs. ABOS (-25.581). GLSI has higher annual earnings (EBITDA): -18.14M vs. ABOS (-132.35M). ABOS has more cash in the bank: 143M vs. GLSI (3.13M). ABOS (0) and GLSI (0) have equivalent revenues.
ABOSGLSIABOS / GLSI
Capitalization74.5M161M46%
EBITDA-132.35M-18.14M730%
Gain YTD-25.5815.076-504%
P/E RatioN/AN/A-
Revenue00-
Total Cash143M3.13M4,576%
Total Debt30.1MN/A-
TECHNICAL ANALYSIS
Technical Analysis
ABOSGLSI
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
87%
Momentum
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
88%
MACD
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 6 days ago
78%
Bullish Trend 13 days ago
77%
Declines
ODDS (%)
Bearish Trend 8 days ago
88%
Bearish Trend 7 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
78%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 5 days ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
ABOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GLSI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SDMHF218.038.92
+4.27%
Sartorius Stedim Biotech
NCCGF1.97N/A
N/A
NCC Group Plc, Manchester
PVBK10.60N/A
N/A
Pacific Valley Bancorp
HBRIY2.85N/A
N/A
Harbour Energy Plc
NSVGF0.01N/A
N/A
Nass Vy Gateway Ltd.

ABOS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABOS has been loosely correlated with KYTX. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if ABOS jumps, then KYTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABOS
1D Price
Change %
ABOS100%
+1.59%
KYTX - ABOS
45%
Loosely correlated
+12.41%
CRBU - ABOS
45%
Loosely correlated
+14.20%
CELC - ABOS
43%
Loosely correlated
+1.18%
GLSI - ABOS
43%
Loosely correlated
+2.97%
BEAM - ABOS
43%
Loosely correlated
+0.37%
More

GLSI and

Correlation & Price change

A.I.dvisor indicates that over the last year, GLSI has been loosely correlated with IMNM. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if GLSI jumps, then IMNM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLSI
1D Price
Change %
GLSI100%
+2.97%
IMNM - GLSI
44%
Loosely correlated
+4.05%
ABOS - GLSI
43%
Loosely correlated
+1.59%
MNMD - GLSI
40%
Loosely correlated
+5.53%
STRO - GLSI
39%
Loosely correlated
+0.39%
OCUL - GLSI
39%
Loosely correlated
+0.83%
More